Artivion | CRY - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Abbott USD 18.38B 1.88B 2026-03
Accuray USD 199.44M 4.83M 2025-12
AngioDynamics USD 71.96M 3.68M 2025-09
Artivion USD 92.7M 8.86M 2026-03
AtriCure USD 73.19M 8.33M 2026-03
Baxter International USD 3.69B 723M 2026-03
Becton, Dickinson and Co. USD 8.51B 254M 2026-03
Boston Scientific USD 4.57B 868M 2026-03
Edwards Lifesciences USD 1.41B 404.7M 2026-03
Inogen USD 64.94M 2.12M 2025-09
Integra LifeSciences USD 346.85M 109.14M 2026-03
J&J USD 57.72B 3.59B 2026-03
Mesa Laboratories USD 54.4M 6.1M 2025-12
Orthofix International USD 161.03M 9.45M 2026-03
Pfizer USD 34.35B 2.64B 2026-03
ResMed USD 1.35B 103.1M 2026-03
Stryker USD 6.32B 1.48B 2026-03
Tandem Diabetes Care USD 247.96M 5.24M 2026-03
Teleflex USD 728.05M 33.98M 2026-03
Terumo JPY 540.73B 1.03B 2026-03
Trinity Biotech USD 34.49M 2.97M 2025-09